The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of pembrolizumab plus olaparib for the treatment of patients with persistent/recurrent endometrial cancers.
 
Maria Rubinstein
Honoraria - MJH Life Sciences; OncLive/MJH Life Sciences
Research Funding - ASCO (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Duality Biologics (Inst); Faeth Therapeutics (Inst); Merck (Inst); Summit Therapeutics (Inst)
 
Qin Zhou
Other Relationship - Morgan and Morgan Complex Litigation Group
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Bristol Myers Squibb; Intelligencia; Mirati Therapeutics
 
Pier Selenica
No Relationships to Disclose
 
Britta Weigelt
Employment - AstraZeneca (I)
Stock and Other Ownership Interests - Repare Therapeutics (I)
Consulting or Advisory Role - Bain Capital Life Sciences (I); PAIGE (I); Repare Therapeutics (I); SAGA Diagnostics (I); Volition RX (I)
Research Funding - Repare Therapeutics (Inst); SAGA Diagnostics (Inst)
 
Caitlin Kaczynski
No Relationships to Disclose
 
Kelsey Higgins
No Relationships to Disclose
 
Pooja Shah
No Relationships to Disclose
 
Viktoriya Paroder
Stock and Other Ownership Interests - Gilead Sciences
 
Ying Liu
Consulting or Advisory Role - Myriad Genetics
Research Funding - Artios (Inst); AstraZeneca (Inst); Repare Therapeutics (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Myriad Genetics
 
Sminu Bose
No Relationships to Disclose
 
Seth Cohen
No Relationships to Disclose
 
Angela Green
Stock and Other Ownership Interests - Main Street Health
Consulting or Advisory Role - Main Street Health; Merck; Stemline Therapeutics
Research Funding - AADi (Inst); Lilly (Inst); Mereo BioPharma (Inst)
 
Rachel Grisham
Employment - Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - AstraZeneca; Corcept Therapeutics; GlaxoSmithKline; Intellisphere; Signatera; SpringWorks Therapeutics; Verastem
Research Funding - Bayer (Inst); Context Therapeutics (Inst); Novartis (Inst); SpringWorks Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; Cardinal Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem
 
Jason Konner
No Relationships to Disclose
 
Chrisann Kyi
Honoraria - OncLive/MJH Life Sciences; Total Health
Consulting or Advisory Role - Scenic Biotech
Research Funding - Acrivon Therapeutics; Bristol Myers Squibb,; Centessa Pharmaceuticals; Eisai; Gritstone Bio; Incyte; Merus
Travel, Accommodations, Expenses - Gritstone Bio
 
Roisin O'Cearbhaill
Honoraria - Aptitude Health; Curio Science; GlaxoSmithKline; GOG Foundation; MJH/PER
Consulting or Advisory Role - 2seventy bio; GlaxoSmithKline; GOG Foundation; Immunogen; Loxo/Lilly; Miltenyi Biotec; Regeneron; Seagan; Takeda Science Foundation
Research Funding - Acrivon Therapeutics (Inst); ArsenalBio (Inst); AstraZeneca/Merck (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Context Therapeutics (Inst); Debiopharm Group (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Ludwig Institute for Cancer Research (Inst); Lyell Immunopharma (Inst); Merck/Genentech (Inst); Mural Oncology (Inst); OnCusp Therapeutics (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Syndax (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
Travel, Accommodations, Expenses - Gathering Around Cancer; Society of Gynecologic Oncology
Other Relationship - JAMA Oncology
 
William Tew
No Relationships to Disclose
 
Carol Aghajanian
Leadership - GOG Foundation; NRG Oncology
Consulting or Advisory Role - AstraZeneca; Merck; WCG
Research Funding - Abbvie (Inst); Artios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Vicky Makker
Consulting or Advisory Role - ArQule; Clovis Oncology; DualityBio; Eisai; Faeth Therapeutics; GlaxoSmithKline; IBM; ITeos Therapeutics; Kartos Therapeutics; Karyopharm Therapeutics; Lilly; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Eisai (Inst); Faeth Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; ESMO Congress; Merck
Other Relationship - IBM